fig4

COVID-19 and rare diseases: reflections and recommendations by the International Rare Diseases Research Consortium

Figure 4. Member organizations who responded to the COVID-19 pandemic by surveying key stakeholders. Over half of the organizations surveyed reported conducting their own survey of key stakeholders (A). Of those, the majority were willing to share their findings (B).

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/